C
Celon Pharma SA
WSE:CLN
Celon Pharma SA
WSE:CLN
Price:
21
PLN
-0.94%
Market Closed
Market Cap:
zł1.1B
Relative Value
The Relative Value of one CLN stock under the Base Case scenario is hidden PLN. Compared to the current market price of 21 PLN, Celon Pharma SA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CLN Relative Value
HIDDEN
Multiples Across Competitors
CLN Competitors Multiples
Celon Pharma SA Competitors
Celon Pharma SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
C
|
Celon Pharma SA
WSE:CLN
|
1.1B PLN | 4.9 | -9.3 | -25.5 | -12 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.7B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.3B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.6B CHF | 4.2 | 19.9 | 11.8 | 13.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.3B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.8B CHF | 5.4 | 21.6 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.4B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.5B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.5 | 17.3 | 7.3 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
